Elisabeth Breit

633 total citations
8 papers, 315 citations indexed

About

Elisabeth Breit is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elisabeth Breit has authored 8 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elisabeth Breit's work include Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Treatment and Pharmacology (2 papers). Elisabeth Breit is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Treatment and Pharmacology (2 papers). Elisabeth Breit collaborates with scholars based in Germany, Switzerland and United States. Elisabeth Breit's co-authors include Klaus Pantel, Michael R. Speicher, Sabine Langer, Uwe Pichlmeier, Georgia Lahr, Günter Schlimok, P. Scheunemann, Jens Köllermann, M. W. Köllermann and R. Oberneder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Journal of Immunological Methods.

In The Last Decade

Elisabeth Breit

8 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Breit Germany 7 210 174 86 64 25 8 315
Yatish Patil United Kingdom 6 245 1.2× 98 0.6× 117 1.4× 30 0.5× 21 0.8× 7 343
Julia Burkert United Kingdom 6 196 0.9× 76 0.4× 197 2.3× 47 0.7× 23 0.9× 11 354
Christian Vay Germany 9 314 1.5× 202 1.2× 205 2.4× 87 1.4× 32 1.3× 14 468
Xiaoyu Pu China 6 297 1.4× 182 1.0× 108 1.3× 101 1.6× 15 0.6× 12 403
Chunyi Shen China 12 232 1.1× 149 0.9× 263 3.1× 91 1.4× 21 0.8× 17 533
Andrea Walens United States 10 194 0.9× 82 0.5× 173 2.0× 43 0.7× 24 1.0× 18 370
Chanthirika Ragulan United Kingdom 5 327 1.6× 90 0.5× 134 1.6× 31 0.5× 29 1.2× 11 414
Rosa Saltarelli Italy 5 304 1.4× 185 1.1× 78 0.9× 110 1.7× 8 0.3× 9 356
Anne M. Macgregor‐Das United States 10 403 1.9× 196 1.1× 202 2.3× 63 1.0× 21 0.8× 11 494
Rachel Payne United Kingdom 7 267 1.3× 292 1.7× 110 1.3× 107 1.7× 52 2.1× 8 387

Countries citing papers authored by Elisabeth Breit

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Breit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Breit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Breit more than expected).

Fields of papers citing papers by Elisabeth Breit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Breit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Breit. The network helps show where Elisabeth Breit may publish in the future.

Co-authorship network of co-authors of Elisabeth Breit

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Breit. A scholar is included among the top collaborators of Elisabeth Breit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Breit. Elisabeth Breit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Reinisch, Mattea, et al.. (2021). Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers. Orphanet Journal of Rare Diseases. 16(1). 363–363. 3 indexed citations
2.
Breit, Elisabeth, et al.. (2021). Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice. Cancers. 13(18). 4564–4564. 9 indexed citations
3.
Prader, Sonia, Andreas du Bois, Philipp Harter, et al.. (2020). Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients. Archives of Gynecology and Obstetrics. 301(3). 729–736. 20 indexed citations
4.
Ataseven, Beyhan, Philipp Harter, Alexander Traut, et al.. (2019). Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trial. Supportive Care in Cancer. 28(8). 3605–3615. 16 indexed citations
5.
Wöelfle, Ute, Elisabeth Breit, Marcus Otte, et al.. (2005). Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients. Journal of Immunological Methods. 300(1-2). 136–145. 40 indexed citations
6.
Wöelfle, Ute, Elisabeth Breit, & Klaus Pantel. (2005). Influence of immunomagnetic enrichment on gene expression of tumor cells.. Journal of Translational Medicine. 3(1). 12–12. 13 indexed citations
7.
Langer, Sabine, et al.. (2004). Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients. Clinical Cancer Research. 10(10). 3457–3464. 81 indexed citations
8.
Lahr, Georgia, Elisabeth Breit, P. Scheunemann, et al.. (2002). Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proceedings of the National Academy of Sciences. 99(4). 2246–2251. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026